After switching to HFHD, patients with diabetes continued to exhibit significantly lower NETosis markers than those without diabetes following HFHD treatment, including MPO (P = 0.03, n = 10) and H3 (P = 0.03, n = 9) (Figure 2b). This evidence concerns the gene MPO and diabetes mellitus.